Evotec SE today announced the most advanced asset arising from their joint venture with Exscientia has entered human clinical trials. The A2a receptor antagonist, which is in development for adult patients with advanced solid tumours, was co-invented and developed between Exscientia and Evotec, including application of Exscientia’s next generation 3-D evolutionary AI-design platform, Centaur Chemist®. The drug candidate has potential for best-in-class characteristics, with high selectivity for the target receptor, bringing together potential benefits of reduced systemic side effects as well as minimal brain exposure to avoid potential undesired centrally-mediated side effects. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-and-exscientia-announce-start-of-human-clinical-trials-of-novel-immuno-oncology-drug-6045
symlife® Lösungen für die Balance des Geschmacks in Produkten mit weniger Zucker, Salz und Fett
— Erfüllt Verbraucherwünsche nach gutem Geschmack und gesünderer Ernährung in Einem
— Ausgewogenes Geschmacksprofil für Produkte mit weniger Zucker, Salz und Fett
— Ganzheitlicher Ansatz mit starkem Fokus auf Natürlichkeit Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.symrise.com/de/newsroom/artikel/symlifeR-loesungen-fuer-die-balance-des-geschmacks-in-produkten-mit-weniger-zucker-salz-und-fett/
Symrise stellt das Geschäft mit kosmetischen Wirkstoffen und Parfümkompositionen organisatorisch neu auf
— Dr. Jörn Andreas verantwortet den Geschäftsbereich Cosmetic Ingredients
— Eder Ramos zeichnet künftig verantwortlich für den Geschäftsbereich Fragrance
— Ausbau wachstumsstarker Geschäftsbereiche & kundenorientierter Servicemodelle Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.symrise.com/de/newsroom/artikel/symrise-stellt-das-geschaeft-mit-kosmetischen-wirkstoffen-und-parfuemkompositionen-organisatorisch-neu/
Is Trypan Blue Toxic? The Dark Side of the Popular Stain
The Gold Standard Dye for Cell Counting?
– 5 min read
You can’t encounter cell counting without hearing about trypan blue. The characteristic blue color of stained cells is something that most of us associate with microscopy of biological samples. Trypan blue has become fixed inventory in laboratories across the world that are working with cell counting and cell viability estimation. The stain was initially synthesized by Paul Ehrlich in 1904 to treat trypanosomiasis in mice1. Since its invention, the non-viable cell stain has experienced huge popularity in connection to cell counting. However, the excitement about this stain is wearing off due to its toxicity and the possible carcinogenic effects it can have on the operator2.
This blog post will cover:
- Critical considerations before using trypan blue
- Trypan blue alternatives
Why the Trypan Blue in your Laboratory Should Be Replaced Immediately!
A web search on trypan blue quickly reveals that it is a widely used dye to determine cell viability. Because it is commonly used, it might not cross many peoples’ minds that the chemical they are handling is carcinogenic and can cause genetic defects2.
With this fact in mind, perhaps it is time to move on from the use of trypan blue for staining cells. Can this change be made overnight? Of course not, but we need to start paying more attention to our consumption habits—also regarding the chemicals we use.
We will only start seeing a change when more businesses find the resources to restructure protocols and workflows to eliminate the use of trypan blue.
This doesn’t only apply to businesses. As scientists, we carry some of the responsibility too. We face decisions on whether to use one chemical or another every day.
Should we purposely expose ourselves to danger by using trypan blue? At a time where sustainability, ecology and health is highly valued, why don’t we pay more attention to the substances that we are working with daily?
Four Alternative Stains for Cell Viability Determination
To minimize the use of trypan blue for cell viability determination, we must go for the alternatives. Four cell stains including some equivalents to trypan blue are listed here.
- Propidium iodide (PI) can stain the DNA or RNA of non-viable cells with damaged membranes. However, there are reports of the use of PI resulting in an underestimation of cell viability, as opposed to trypan blue, which can lead to overestimation3. PI isn’t classified as having any carcinogenic effects4.
- Erythrosine B stains non-viable cells because the non-intact cell membrane of these cells allows the dye to pass into the cell. It is not classified as carcinogenic and isn’t toxic, which is also why erythrosine B is commonly used as a food dye5,6.
- Acridine orange (AO) stains all cells by its interaction with DNA. Because of its membrane permeability, it can be used to determine the total amount of cells in a sample. According to the European Chemical Agency (ECHA), AO isn’t carcinogenic7,8.
- 4′,6-diamidino-2-phenylindole dihydrochloride (DAPI) cannot permeate the cell membrane, and therefore DAPI is suitable for staining non-viable cells. These cells leave the DNA exposed, since they don’t have intact cellular and nuclear membranes. Unlike trypan blue, DAPI isn’t carcinogenic7,9.
A safe choice when performing cell viability assays is to include different types of stains that can indicate both the total amount of cells and the number of non-viable cells, for a viability calculation. Here, a combination of the fluorescent stains AO and DAPI will provide an overview of the condition of the cells in the cell sample. Want to know more? Read about how the Via2-Cassette™ uses these dyes.
Learn More
Want to know more about the issues of using trypan blue in your cell counting? Watch ChemoMetec’s trypan blue webinar with a short presentation and a Q&A section addressing customer questions. Or read one of these resources:
- Webinar: Accurately Measuring Cell Viability: Are All Viability Dyes Created Equal?
- Webinar: Why is trypan blue toxic and unsafe to use?
- Mini Review: Manual vs Automated Cell counting
- Mini Review: Why Working with Trypan Blue is Not a Good Idea
- Product: Via2-Cassette™
References
- HP Morgan, IW McNae, MW Nowicki et al.: The Trypanocidal Drug Suramin and Other Trypan Blue Mimetics Are Inhibitors of Pyruvate Kinases and Bind to the Adenosine Site, Journal of Biological Chemistry, Volume 286, Issue 36, 2011, p. 31232-31240
- European Chemical Agency (ECHA): Substance Infocard: Tetrasodium 3,3′-[(3,3′-dimethyl[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonate]
- C Kirchhoff, H Cypionka, Propidium ion enters viable cells with high membrane potential during live-dead staining. Journal of Microbiological Methods, Volume 142, 2017, p. 79-82
- European Chemical Agency (ECHA): Substance Infocard: 3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diiodide
- European Chemical Agency (ECHA): Substance Infocard: Erythrosin B
- S Kamiloglu, G Sari, T Ozdal et al.: Guidelines for cell viability assays. Food Frontiers, 2020.
- European Chemical Agency (ECHA): Substance Infocard: N,N,N’,N’-tetramethylacridin-3,6-yldiamine hydrochloride
- ChemoMetec: Why working with trypan blue is not a good idea
- European Chemical Agency (ECHA): Substance Infocard: 2-phenylindole-4′,6-dicarboxamidine dihydrohydrochloride (hydrate)
By Christina Psaradaki, Student Assistant at ChemoMetec
Christina Psaradaki studies Human Life Science Engineering at the Technical University of Denmark. At ChemoMetec, she writes for the Cell Counting Blog.
Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://chemometec.com/is-trypan-blue-toxic/
The Science Pool: Evotec’s New Scientific Content Hub
Knowledge sharing within the scientific community is a key focus for Evotec. Sharing resources will help to collectively advance R&D and accelerate innovation – ultimately leading to new technology and therapies reaching the market faster. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/the-science-pool-evotecs-new-scientific-content-hub-6043
Evotec SE fiscal year 2020 results: Gaining speed on the "data-driven R&D Autobahn to Cures"
Very strong financial results: 12% increase in Group revenues beating guidance despite pandemic; unique innovation platforms and infrastructure support long-term growth in all modalities; solid balance sheet, strong foundation for next expansion steps Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-se-fiscal-year-2020-results-gaining-speed-on-the-data-driven-rd-autobahn-to-cures-6042
Evotec and Takeda enter strategic RNA targeting drug discovery and development alliance
Evotec SE today announced that the Company has entered into a multi-RNA target alliance with Takeda Pharmaceutical Company Limited (“Takeda”) with the goal to discover and develop RNA targeting small molecule therapeutics for highly attractive targets that are difficult to address via more conventional approaches. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-and-takeda-enter-strategic-rna-targeting-drug-discovery-and-development-alliance-6038
Evotec SE to announce results for fiscal year 2020 on 25 March 2021
Evotec SE will announce its financial results for 2020 on Thursday, 25 March 2021. The Company is going to hold a conference call to discuss the results as well as to provide an update on its performance. The conference call will be held in English. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-se-to-announce-results-for-fiscal-year-2020-on-25-march-2021-6034
CMO Leadership Awards 2021
Evotec announces that the Company has been selected as a winner of a 2021 CMO Leadership Award in the categories Compatibility (Big Pharma), Expertise (Big Pharma), and Service (Overall, Small Pharma) Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/cmo-leadership-awards-2021-6036
Symrise tritt AIM-Progress Initiative für nachhaltigere und gerechtere Lieferketten bei
— Initiative setzt sich für Nachhaltigkeit und Einhaltung von Menschenrechten ein
— Verbessert Kooperation mit Kunden und Lieferanten Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.symrise.com/de/newsroom/artikel/symrise-tritt-aim-progress-initiative-fuer-nachhaltigere-und-gerechtere-lieferketten-bei/